Velphoro (sucroferric oxyhydroxide) — Point32Health
Control of serum phosphorus levels in patients with chronic kidney disease on dialysis
Preferred products
- sevelamer (generic sevelamer [Renagel], Renvela)
- lanthanum (Fosrenol)
Initial criteria
- Diagnosis of hyperphosphatemia in the setting of chronic kidney disease (CKD) requiring dialysis
- Prescriber is a physician specializing in renal diseases or is in consultation with a nephrologist
- For age ≥ 18 years: trial and failure, inadequate response, intolerance, or contraindication to BOTH of the following formulary alternatives: sevelamer (generic sevelamer [Renagel], Renvela) AND lanthanum (Fosrenol)
- For age 9 to 17 years: trial and failure, inadequate response, intolerance, or contraindication to sevelamer (generic sevelamer [Renagel], Renvela)